Health Care & Life Sciences » Pharmaceuticals | Sinco Pharmaceuticals Holdings Ltd.

Sinco Pharmaceuticals Holdings Ltd.

Sinco Pharmaceuticals Holdings Ltd.
Stock Exchange Hong Kong Stock Exchange
EPS
HKD0.19
Market Cap
HKD600.62 M
Shares Outstanding
1.69 B
Public Float
528.68 M

Profile

Address
E5-1805, Global Centre
Chengdu Sichuan 610041
China
Employees -
Website http://www.sinco-pharm.com
Updated 07/08/2019
Sinco Pharmaceuticals Holdings Ltd. engages in the marketing, promotion, and channel management services for pharmaceutical products and medical devices. It improves human plasma-based pharmaceutical, antibiotics, and other pharmaceuticals focused on therapeutic areas complementary to human plasma-based products. It offers human albumin solution, Axetine, Medocef, and Trifamox IBL.

Financials

View All
Created with Highcharts 5.0.14Sinco Pharmaceuticals Holdings Ltd.Net Income. Fiscal year is January-December. All values HKD Millions.46468787868623232142143323322013201420152016201720180100200300400
Created with Highcharts 5.0.14Sinco Pharmaceuticals Holdings Ltd.Sales/Revenue. Fiscal year is January-December. All values HKD Millions.6726721 1961 1961 3521 3521 0041 0049309301 1291 1292013201420152016201720180250500750100012501500

Xiang Bin Huang
Chairman & Co-Chief Executive Officer
Wen Fang Liu
Independent Non-Executive Director